Literature DB >> 27702819

Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway.

Semir Beyaz1,2,3, Ömer H Yilmaz4,2,5.   

Abstract

Peroxisome proliferator-activated receptor delta (PPAR-δ) is a nuclear receptor transcription factor that regulates gene expression during development and disease states, such as cancer. However, the precise role of PPAR-δ during tumorigenesis is not well understood. Recent data suggest that PPAR-δ may have context-specific oncogenic and tumor-suppressive roles depending on the tissue, cell-type, or diet-induced physiology in question. For example, in the intestine, pro-obesity diets, such as a high-fat diet (HFD), are associated with increased colorectal cancer incidence. Interestingly, many of the effects of an HFD in the stem and progenitor cell compartment are driven by a robust PPAR-δ program and contribute to the early steps of intestinal tumorigenesis. Importantly, the PPAR-δ pathway or its downstream mediators may serve as therapeutic intervention points or biomarkers in colon cancer that arise in patients who are obese. Although potent PPAR-δ agonists and antagonists exist, their clinical utility may be enhanced by uncovering how PPAR-δ mediates tumorigenesis in diverse tissues and cell types as well as in response to diet. Clin Cancer Res; 22(23); 5636-41. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27702819      PMCID: PMC5135602          DOI: 10.1158/1078-0432.CCR-16-0775

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  60 in total

1.  Critical roles of PPAR beta/delta in keratinocyte response to inflammation.

Authors:  N S Tan; L Michalik; N Noy; R Yasmin; C Pacot; M Heim; B Flühmann; B Desvergne; W Wahli
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  Peroxisome proliferator-activated receptor-delta polymorphisms are associated with physical performance and plasma lipids: the HERITAGE Family Study.

Authors:  Arto J Hautala; Arthur S Leon; James S Skinner; D C Rao; Claude Bouchard; Tuomo Rankinen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-26       Impact factor: 4.733

3.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

4.  Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.

Authors:  Lie Yang; Hong Zhang; Zong-Guang Zhou; Hui Yan; G Adell; Xiao-Feng Sun
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

5.  Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells.

Authors:  Huan Huang; Olga Starodub; Avery McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

6.  Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.

Authors:  H Poirier; I Niot; M C Monnot; O Braissant; C Meunier-Durmort; P Costet; T Pineau; W Wahli; T M Willson; P Besnard
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

7.  15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.

Authors:  Simone Naruhn; Wolfgang Meissner; Till Adhikary; Kerstin Kaddatz; Thomas Klein; Bernhard Watzer; Sabine Müller-Brüsselbach; Rolf Müller
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

8.  Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.

Authors:  Xiangsheng Zuo; Zhanglong Peng; Micheline J Moussalli; Jeffrey S Morris; Russell R Broaddus; Susan M Fischer; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2009-05-12       Impact factor: 13.506

9.  The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta.

Authors:  Yael Riahi; Yoav Sin-Malia; Guy Cohen; Evgenia Alpert; Arie Gruzman; Juergen Eckel; Bart Staels; Michel Guichardant; Shlomo Sasson
Journal:  Diabetes       Date:  2010-01-27       Impact factor: 9.461

10.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.

Authors:  Moses T Bility; Meghann K Devlin-Durante; Nicholas Blazanin; Adam B Glick; Jerrold M Ward; Boo Hyon Kang; Mary J Kennett; Frank J Gonzalez; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2008-09-17       Impact factor: 4.741

View more
  15 in total

1.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

2.  PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells.

Authors:  L Sun; Y Shi; G Wang; X Wang; S Zeng; S E Dunn; G D Fairn; Y-J Li; D E Spaner
Journal:  Leukemia       Date:  2017-05-30       Impact factor: 11.528

Review 3.  The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer.

Authors:  Lakshmipathi Vadlakonda; Meera Indracanti; Suresh K Kalangi; B Meher Gayatri; Navya G Naidu; Aramati B M Reddy
Journal:  J Diabetes Metab Disord       Date:  2020-08-19

4.  Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis.

Authors:  Semir Beyaz; Charlie Chung; Haiwei Mou; Khristian E Bauer-Rowe; Michael E Xifaras; Ilgin Ergin; Lenka Dohnalova; Moshe Biton; Karthik Shekhar; Onur Eskiocak; Katherine Papciak; Kadir Ozler; Mohammad Almeqdadi; Brian Yueh; Miriam Fein; Damodaran Annamalai; Eider Valle-Encinas; Aysegul Erdemir; Karoline Dogum; Vyom Shah; Aybuke Alici-Garipcan; Hannah V Meyer; Deniz M Özata; Eran Elinav; Alper Kucukural; Pawan Kumar; Jeremy P McAleer; James G Fox; Christoph A Thaiss; Aviv Regev; Jatin Roper; Stuart H Orkin; Ömer H Yilmaz
Journal:  Cell Stem Cell       Date:  2021-09-15       Impact factor: 25.269

Review 5.  Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Angela Nigro; Valentina Lucia La Rosa; Paola Rossetti; Agnese Maria Chiara Rapisarda; Sandro La Vignera; Rosita Angela Condorelli; Francesco Corrado; Massimo Buscema; Rosario D'Anna
Journal:  PPAR Res       Date:  2016-12-28       Impact factor: 4.964

6.  Multi-label Deep Learning for Gene Function Annotation in Cancer Pathways.

Authors:  Renchu Guan; Xu Wang; Mary Qu Yang; Yu Zhang; Fengfeng Zhou; Chen Yang; Yanchun Liang
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

Review 7.  Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer.

Authors:  Federica Francescangeli; Maria Laura De Angelis; Ann Zeuner
Journal:  Nutrients       Date:  2019-12-03       Impact factor: 5.717

8.  High-fat diet activates a PPAR-δ program to enhance intestinal stem cell function.

Authors:  Semir Beyaz; Miyeko D Mana; Ömer H Yilmaz
Journal:  Cell Stem Cell       Date:  2021-04-01       Impact factor: 24.633

9.  High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity.

Authors:  Miyeko D Mana; Amanda M Hussey; Constantine N Tzouanas; Shinya Imada; Yesenia Barrera Millan; Dorukhan Bahceci; Dominic R Saiz; Anna T Webb; Caroline A Lewis; Peter Carmeliet; Maria M Mihaylova; Alex K Shalek; Ömer H Yilmaz
Journal:  Cell Rep       Date:  2021-06-08       Impact factor: 9.423

10.  Induction of apoptosis in prostate cancer by ginsenoside Rh2.

Authors:  Tony Tong-Lin Wu; Yat-Ching Tong; I-Hung Chen; Ho-Shan Niu; Yingxiao Li; Juei-Tang Cheng
Journal:  Oncotarget       Date:  2018-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.